These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7328173)

  • 1. Induction of antimyelin and antioligodendrocyte antibodies by vaccinia virus. An experimental study in the mouse.
    Steck AJ; Tschannen R; Schaefer R
    J Neuroimmunol; 1981 Mar; 1(1):117-24. PubMed ID: 7328173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study with an anti-myelin serum. A marker for all glial cells except 'dark' oligodendrocytes.
    Roussel G; Nussbaum JL
    J Neuroimmunol; 1983 Dec; 5(3):209-26. PubMed ID: 6361066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF antibodies to myelin basic protein and oligodendrocytes in multiple sclerosis and other neurological diseases.
    Górny MK; Wróblewska Z; Pleasure D; Miller SL; Wajgt A; Koprowski H
    Acta Neurol Scand; 1983 Jun; 67(6):338-47. PubMed ID: 6193672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocyte-binding antibodies in multiple sclerosis: 125I-protein A studies.
    Steck AJ; Regli F
    Neurology; 1980 May; 30(5):540-2. PubMed ID: 7189260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental allergic encephalomyelitis: serum immunoglobulin binds to myelin and oligodendrocytes in cultured tissue: ultrastructural-immunoperoxidase observations.
    Johnson AB; Raine CS; Bornstein MB
    Lab Invest; 1979 May; 40(5):568-75. PubMed ID: 374865
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of antioligodendrocyte serum.
    Traugott U; Snyder S; Norton WT; Raine CS
    Ann Neurol; 1978 Nov; 4(5):431-9. PubMed ID: 367262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to oligodendroglia in patients with multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
    N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies to myelin cerebrosides and their role in the pathogenesis of autoimmune demyelinating diseases (review)].
    Taranova NP; Kirchik OS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(12):1863-72. PubMed ID: 3911691
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of membrane markers of isolated oligodendrocytes and clonal lines of the nervous system.
    Steck AJ; Perruisseau G
    J Neurol Sci; 1980 Jul; 47(1):135-44. PubMed ID: 7411160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.
    Scolding NJ; Morgan BP; Houston A; Campbell AK; Linington C; Compston DA
    J Neurol Sci; 1989 Feb; 89(2-3):289-300. PubMed ID: 2926453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demyelination in brain cell aggregate cultures, induced by a monoclonal antibody against the myelin/oligodendrocyte glycoprotein (MOG).
    Honegger P; Matthieu JM; Lassmann H
    Schweiz Arch Neurol Psychiatr (1985); 1989; 140(1):10-3. PubMed ID: 2467359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological studies in demyelinating encephalitis associated with vaccinia virus and canine distemper virus infection.
    Steck AJ; Vandevelde M
    Prog Brain Res; 1983; 59():275-9. PubMed ID: 6198680
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody-dependent cellular cytotoxicity in antimyelin antibody-induced oligodendrocyte damage in vitro.
    Griot-Wenk M; Griot C; Pfister H; Vandevelde M
    J Neuroimmunol; 1991 Aug; 33(2):145-55. PubMed ID: 2066397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.
    Schluesener HJ; Sobel RA; Linington C; Weiner HL
    J Immunol; 1987 Dec; 139(12):4016-21. PubMed ID: 3500978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell that are O4 antigen-positive and O1 antigen-negative differentiate into O1 antigen-positive oligodendrocytes.
    Sommer I; Schachner M
    Neurosci Lett; 1982 Apr; 29(2):183-8. PubMed ID: 6178060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes.
    Suzumura A; Lavi E; Weiss SR; Silberberg DH
    Science; 1986 May; 232(4753):991-3. PubMed ID: 3010460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
    Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
    Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.
    Rodriguez M; Leibowitz JL; Lampert PW
    Ann Neurol; 1983 Apr; 13(4):426-33. PubMed ID: 6340596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cellular cytotoxicity (ADCC) in antimyelin antibody-induced oligodendrocyte damage in vitro.
    Griot-Wenk M; Griot C; Pfister H; Vandevelde M
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):122-3. PubMed ID: 1710381
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells.
    Suzumura A; Lavi E; Bhat S; Murasko D; Weiss SR; Silberberg DH
    J Immunol; 1988 Mar; 140(6):2068-72. PubMed ID: 2831279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.